Skip to main content
PLEASE NOTE: For everyone’s safety, Fasken requires anyone on-site at our Canadian offices to provide proof of full vaccination against COVID-19. This applies to lawyers, staff, clients, service providers and other visitors.
Timothy Squire Toronto Lawyer

Timothy M. Squire *

Partner Fasken
Increasing government regulation continues to put more pressure on the life sciences sector in Canada.
Jurisdiction Ontario, 1997
Language(s) English
Office(s) Toronto
*practising through a professional corporation

Timothy Squire is one of Canada's leading Life Sciences Industry Specialists. With his extensive regulatory and commercialization experience, Tim has become a trusted advisor to stakeholders in the drug, medical device, natural health product, cosmetic and food industries in Canada and from around the world.

Tim’s practice is devoted to the Life Sciences industry, and he is the former Chair of the firm's International Life Sciences Industry Group. He adds substantial bench strength given his extensive knowledge and experience across the entire health product lifecycle. Tim has become a trusted advisor to many stakeholders in the drug, medical device, natural health product, cosmetic and food industries in Canada and around the world due to his expertise and commitment to client service.

Tim's regulatory practice covers all aspects of health product regulation and market access, and he is one of the few specialists in Canada regularly called upon to help solve complex health product compliance and enforcement issues. To this end, Tim frequently communicates with Health Canada and other federal and provincial regulators on our clients’ behalf.  

In addition to his regulatory expertise, Tim also negotiates and drafts sophisticated commercial arrangements for Life Sciences clients, including license agreements, distribution agreements, manufacturing and supply agreements, quality and pharmacovigilance agreements, technology and material transfer agreements, joint R&D agreements, and funding agreements.

Tim also quarterbacks regulatory due diligence in complex domestic and cross-border transactions involving drug, medical device, natural health product, cosmetic, and food companies, and is often called upon to manage post-closing integration, including the transition of market authorizations and regulatory operations.

Tim performs in-house legal functions for several U.S. and international clients without Canadian in-house legal or regulatory capabilities, and in this capacity has developed a comprehensive understanding of the business issues and pressures facing companies in the life sciences industry.

Tim’s expertise in the life sciences sector has been recognized by Chambers Canada, Who’s Who Legal, Lexpert, IAM Strategy 300: The World’s Leading IP Strategists, and he has received LMG’s Life Sciences Canadian Regulatory Attorney of the Year award three times, most recently in 2020.

  • Recognized nationwide in Life Sciences: Regulatory/Compliance, Chambers Canada 2017 to 2022
  • Recognized in the Canadian Legal Lexpert Directory in Biotechnology, Lexpert 2020 to 2021
  • Canadian Regulatory Attorney of the Year 2020, LMG Life Sciences Awards 2020
Date Client


  • LLB University of Windsor
  • BA University of Windsor
Article, Co-Author When is Software a Medical Device? Electronic Healthcare Law Review, LexisNexis, Volume 8, No. 4, May 2019, pages 44-45
Article Canadian Expert Tim Squire: Bill pushing drug imports from Canada is a roundabout solution Stat News
Article U.S. Bill to Import Canadian Drugs Gets Chilly Reception North of the Border International Trade Reporter


    Receive email updates from our team